as in other oecd countries technology is expanding possibilities for life extension and quality and spending is rising steadily while an ageing population requires substantially more and different services the main challenges are to promote prevention and costefficient behaviour by care providers tackle the high spending on pharmaceuticals strengthen the role of health insurers as purchasing agents and secure cost containment goodquality information and appropriate financing schemes would ensure stronger efficiency incentives